proved that radiotherapy combined with anti-CD25 monoclonal antibody therapy reversed the increase of PD-1 expression on CD8+ T cells and CD4+ T cells during the radiotherapy, thereby inhibiting the tumor growth and improving the overall survival rate (108). The gene discussed is CD8A; the disease is neoplasm.